MedPath

Retropubic vs. Transobturator Tension-free Vaginal Tape

Not Applicable
Completed
Conditions
Stress Urinary Incontinence
Interventions
Device: Retropubic Tension-free vaginal tape (TVT)
Device: Transobturator Tension-free vaginal tape (TVT-O)
Registration Number
NCT00441454
Lead Sponsor
Austrian Urogynecology Working Group (AUWG)
Brief Summary

The so-called tension-free vaginal tape (TVT), first described in Sweden in 1996, has become a standard operation worldwide for the treatment of women with stress urinary incontinence. This tape is placed from the vagina behind the pubic bone and exits through the skin of the lower abdomen, just above the pubic bone. In 2001 a urologist in France proposed passing a similar tape laterally (as opposed to behind the pubic bone). This tape is passed through a window of the pelvic bones (the so-called obturator foramen), by what is called a transobturator approach. It is passed through the skin of the thigh (as opposed to the lower abdomen). The reason for this modification was to avoid injuring the bladder and, possibly, provide a more physiologic restoration of the continence mechanism. However, it is unclear whether the lateral (so-called transobturator approach) is as good as or better than the initial approach behind the pubic bone.

The purpose of the present study is to compare the standard (retropubic) and the newer (transobturator) approach for the placement of a tape for treating women with stress urinary incontinence.

Detailed Description

After informed consent women scheduled for surgery for stress urinary incontinence are randomized to receive a tension-free vaginal tape either by the retropubic or the transobturator approach.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
564
Inclusion Criteria
  • Planned surgery for primary stress incontinence (positive stress test at bladder filling of 300 ml) without concomitant prolapse surgery or hysterectomy
  • Patient able and willing to participate in follow-up
  • Informed consent
Exclusion Criteria

´

  • Detrusor overactivity, predominant complaint overactive bladder (OAB)
  • Major concomitant surgery
  • Prolapse beyond introitus or any prolapse necessitating surgery
  • Previous incontinence surgery other than colporrhaphy
  • Residual urine >100 ml
  • Neurologic disease
  • Allergy to local anesthetic agents
  • Coagulation disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ARetropubic Tension-free vaginal tape (TVT)Retropubic Tension-free Vaginal Tape (TVT)
BTransobturator Tension-free vaginal tape (TVT-O)Transobturator Tension-free Vaginal Tape (TVT-O)
Primary Outcome Measures
NameTimeMethod
Continence5 years
Secondary Outcome Measures
NameTimeMethod
Quality of life5 years

Trial Locations

Locations (4)

Dept. OB/GYN, Wilhelminenspital

🇦🇹

Vienna, Austria

Dept. of Gynecology, Krankenhaus der Barmherzigen Brüder

🇦🇹

Graz, Austria

Department of OB/GYN, Medical University of Graz

🇦🇹

Graz, Austria

Dept. OB/GYN, Medical University of Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath